Birmingham, AL, United States of America

Pooran Chand

This inventor holds 31 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Antiviral Treatments. Top assignees: Biocryst Pharmaceuticals, Inc., Advanced Cancer Therapeutics, LLC, University Of Louisville Research Foundation, Inc.. Active years: 1997-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pooran Chand. Retrieved from https://idiyas.com/inventor/pooran-chand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 10)

% Patents Active = 83.9

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 3.8

ph-index = 14

Forward Citations = 649(Granted Patents)

Company Filing History:

25 out of 92

Biocryst Pharmaceuticals, Inc.

patents

4 out of 7

Advanced Cancer Therapeutics, LLC

patents

4 out of 398

University Of Louisville Research Foundation, Inc.

where one patent can have more than one assignee

Years Active: 1997-2024

Loading Chart...

Areas of Expertise:

Antiviral Treatments

PFKFB3 Inhibitors

Small Molecule Inhibitors

Nucleoside Analogs

Hepatitis C Therapies

Neoplastic Disorders

Serine Protease Inhibitors

Cyclopentane Compounds

Macrophage Migration Inhibitory Factor

Viral Infections

Glycolytic Flux

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12121503 - Antiviral treatments (2024-10-22),

2. 11464755 - Antiviral treatments (2022-10-11),

3. 10391075 - Antiviral treatments (2019-08-27),

4. 10010542 - PFKFB3 inhibit and methods of use as an anti-cancer therapeutic (2018-07-03),

5. 9770427 - Antiviral treatments (2017-09-26),

6. 9649305 - PFKFB3 inhibitor and methods of use as an anti-cancer therapeutic (2017-05-16),

7. 9403769 - Small molecule inhibitors of PFKFB3 and glycolytic flux and their methods of use as anti-cancer therapeutics (2016-08-02),

8. 9381172 - Small molecule choline kinase inhibitors, screening assays, and methods for treatment of neoplastic disorders (2016-07-05),

9. 9162987 - Iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (MIF)-implicated diseases and conditions (2015-10-20),

10. 8778997 - Antiviral treatments (2014-07-15),

11. 8557823 - Family of PFKFB3 inhibitors with anti-neoplastic activities (2013-10-15),

12. 8440813 - Antiviral nucleoside analogs (2013-05-14),

13. 8344132 - Methods for the preparation of 9-deazapurine derivatives (2013-01-01),

14. 8242085 - Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer (2012-08-14),

15. 8163703 - Hepatitis C therapies (2012-04-24),

Title: Pooran Chand: Innovator in Antiviral Treatments

Introduction

Pooran Chand is a notable inventor based in Birmingham, AL, with an impressive portfolio of 31 patents. His work in the field of antiviral treatments has significantly contributed to medical advancements, giving hope to many affected by viral infections.

Latest Patents

His latest patents focus on antiviral treatments, providing unit dosage forms, kits, and methods that are vital for effectively treating viral infections. This innovation showcases Pooran's commitment to improving healthcare and patient outcomes.

Career Highlights

Throughout his career, Pooran Chand has made a substantial impact in the pharmaceutical industry by collaborating with leading companies. He has worked with Biocryst Pharmaceuticals, Inc. and Advanced Cancer Therapeutics, LLC, where he developed groundbreaking treatment options.

Collaborations

In his journey as an inventor, Pooran has collaborated with esteemed professionals, including Yarlagadda Sudhakara Babu and Pravin L Kotian. These partnerships have enhanced his ability to innovate and address complex medical challenges.

Conclusion

Pooran Chand's contributions to antiviral treatments through his patents reflect his dedication to science and technology. With his extensive experience and innovative spirit, he continues to pave the way for advancements in healthcare, impacting countless lives in the process.

Profile summary based on public USPTO records.